icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2020
Back grey_arrow_rt.gif
 
 
 
Rapid HBsAg Reduction in Chronic Hepatitis B Virus Infection: Preliminary Results From a Phase 1 Study Evaluating a Single Dose of VIR-3434, a Novel Neutralizing, Vaccinal Monoclonal Antibody
 
 
  AASLD 2021 Nov 12-15
 
Kosh Agarwal,1 Man-Fung Yuen,2 Heiner Wedemeyer,3 Andre Arizpe,4 Ling Shen,4 Daniel Cloutier,4 Chin Tay,4 Sneha V. Gupta,4 Marie Fanget,4 Sanjay L. Dholakiya,4 Lillian Seu,4 Andrea L. Cathcart,4 Carey Hwang,4 Phillip S. Pang,4 and Edward Gane5 1Institute of Liver Studies, Kings College Hospital, London, United Kingdom; 2Queen Mary Hospital, University of Hong Kong, Hong Kong, China; 3Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 4Vir Biotechnology Inc., San Francisco, California, United States; 5University of Auckland, Auckland, New Zealand

1123211

1123212

1123213

1123214

1123215

1123216

1123217